Advance and clinical application of stereotactic ablative radiotherapy in liver and pancreatic cacinoma

doi:10.3877/cma.j.issn.1674-0793.2013.06.019

Abstract

Abstract:

Stereotactic ablative radiotherapy (SABR) is a special type of radiation therapy to deliver a high dose of radiation to the extracranial tumor in one or a small number of fractions with a high degree of precision. The tumor target is destroyed by ionizing irradiation while minimizing the exposure of radiation to normal tissues. SABR has been applied to treat patients with medically inoperable primary hepatocellular carcinoma, non-small-cell lung cancer and so on with promising effect. This article has comprehensively reviewed the clinical application of SABR in liver and pancreatic cancer and the progress in radiophysics and radiobiology of SABR.

Key words: SABR, HCC, Pancreatic cancer, Toxicity, Radiobiological effects

Zhen-yu WANG, Qun ZHANG, Bi-xiu WEN. Advance and clinical application of stereotactic ablative radiotherapy in liver and pancreatic cacinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(06): 496-500.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2013.06.019

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2013/V07/I06/496

References 35

1	Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys, 2004, 60(4): 1026-1032.
2	Galvin JM, Bednarz G. Quality assurance procedures for stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys, 2008, 71(1 Suppl): S122-125.
3	Lo SS, Fakiris AJ, Chang EL, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol, 2010, 7(1): 44-54.
4	Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys, 2010, 37(8): 4078-4101.
5	Timmerman RD, Kavanagh BD. Stereotactic body radiation therapy. Curr Probl Cancer, 2005, 29(3): 120-157.
6	Ibarra RA, Rojas D, Snyder L, et al. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol, 2012, 51(5): 575-583.
7	Goyal K, Einstein D, Yao M, et al. Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results. HPB Surg, 2010, 2010. pii: 309780.
8	Dewas S, Bibault J E, Mirabel X, et al. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy. Radiat Oncol, 2012, 7: 166.
9	Goodman KA, Wiegner EA, Maturen KE, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys, 2010, 78(2): 486-493.
10	Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol, 2006, 45(7): 831-837.
11	Cardenes HR, Price TR, Perkins SM, et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol, 2010, 12(3): 218-225.
12	吕光明，钟南保，陈忠华, 等. 立体定向放射治疗原发性肝癌的疗效分析. 实用肝脏病杂志, 2009, 12(6): 435-436.
13	张重魁，刘红军，陈标, 等. 立体定向放射治疗原发性肝癌的疗效观察. 实用癌症杂志, 2008, 23(3): 288-290.
14	Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol, 2009, 27(10): 1585-1591.
15	Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol, 2009, 27(10): 1572-1578.
16	张烨，肖建平，李晔雄, 等. 体部立体定向放射治疗肝转移瘤22例临床疗效. 中华放射肿瘤学杂志, 2010, 19(2): 135-138.
17	杨志祥，王阁，王东, 等. 立体定向放射治疗肝转移癌临床疗效观察. 重庆医学, 2007, 36(19): 1953-1954.
18	Salama JK, Kirkpatrick JP, Yin FF. Stereotactic body radiotherapy treatment of extracranial metastases. Nat Rev Clin Oncol, 2012, 9(11): 654-665.
19	Schellenberg D, Goodman KA, Lee F, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 2008, 72(3): 678-686.
20	Schellenberg D, Kim J, Christman-Skieller C, et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 2011, 81(1): 181-188.
21	Taniguchi CM, Murphy JD, Eclov N, et al. Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer. Int J Radiat Oncol Biol Phys, 2012,
22	Goyal K, Einstein D, Ibarra RA, et al. Stereotactic body radiation therapy for nonresectable tumors of the pancreas. J Surg Res, 2012, 174(2): 319-325.
23	Mahadevan A, Jain S, Goldstein M, et al. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 2010, 78(3): 735-742.
24	高宏，张虹，邵秋菊, 等. 立体定向放射治疗胰腺癌112例疗效观察. 现代肿瘤医学, 2010, 18(1): 112-113.
25	季洪兵，吕光明，钟南保, 等. 立体定向放射治疗胰腺癌的疗效分析. 实用肝脏病杂志, 2010, 13(6): 436-437, 440.
26	吴铁鹰，张峻青，刘永兰, 等. 立体定向放射治疗联合吉西他滨治疗局部晚期胰腺癌疗效分析. 肿瘤研究与临床, 2012, 24(7): 490-492.
27	季洪兵，吕光明. 立体定向放射治疗原发性肝癌伴下腔静脉癌栓的疗效评价. 实用肝脏病杂志, 2011, 14(1): 37-39.
28	季洪兵，吕光明. 内支架置入联合立体定向放疗治疗肝癌致下腔静脉癌栓临床研究. 中华实用诊断与治疗杂志, 2011, 25(6): 602-604.
29	季洪兵，吕光明，钟南保. 胆管引流联合立体定向放疗治疗恶性梗阻性黄疸临床分析. 中华实用诊断与治疗杂志, 2011, 25(4): 393-395.
30	Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol, 2007, 25(8): 947-952.
31	Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys, 2008, 70(3): 847-852.
32	Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol, 2006, 24(30): 4833-4839.
33	Chang EL, Shiu AS, Lii MF, et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys, 2004, 59(5): 1288-1294.
34	Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine, 2007, 7(2): 151-160.
35	Wolbarst AB, Chin LM, Svensson GK. Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys, 1982, 8(10): 1761-1769.

[1]	Jing Tao, Xiaohong Li, Xi Tan, Li Chen, Aihua Yin, He Wang, Yangyu Zhao, Yong Yang, Xinwen Zhang, Xiaohui Zhang, Xueyan Wang, Dunjin Chen, Juan Du, Suhua Chen, Xiaoqing Jiang, Guoying Zhang, Li Li, Yan Zhang, Jinhua Gu, Fen Li, Lan Xie, Juanjuan Zhao, Chunhong Zhang, Jun Zhu. Technical specification for consultation on the risk of drug teratogenicity during pregnancy [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(04): 393-401.
[2]	Mengsheng Li, Zhongbo Han. High risk and controllable factor of gastric cancer--Helicobacter pylori infection [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(03): 145-150.
[3]	Peizhong Shang, Runping Zhang, Wei Zhang, Guohong Jia, Xiaowu Li, Jianjun Miao, Bing Liu. Clinical application of novel techniques for obstructive jaundice prevention and treatment: a single-center study [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 104-107.
[4]	Jing Huang, Lei Wang. Effect of VitD on reducing the cytotoxicity of PM_2.5 to alveolar epithelial cells [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(04): 481-485.
[5]	Huihua Shen, Guozhu Xing, Wu Li. Clinical value of lung dose and inflammatory cytokines in predicting radiotherapy-induced pulmonary toxicity [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2020, 13(06): 764-768.
[6]	Hu Liu, Bolun Zhang, Hao Yang, Yi Le, Guanghao Diao, Zhaoyang Cui, Xiangning Zhao, Liang An, Haizhu Li, Jianqiang Cai, Shaogeng Zhang. Research of curved water-cooled microwave ablation of diaphragmatic dome of HCC under laparoscopy [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(01): 44-48.
[7]	Qinyun Wang, Dabin Xu, Enli Zhang, Hai Qian, Zhiming Zhao. Da Vinci robot-assisted pancreato-duodenectomy in a patient with situs inversus totalis based on one case [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2023, 16(01): 52-55.
[8]	Xinxiong Li, Zaizhong Zhang, Hu Zhao, Chunhong Xiao, Lie Wang. Progress of exosome contents as diagnostic markers for pancreatic cancer [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(01): 53-57.
[9]	Cuiping Li, Xiaoyan Chen, Shiyu Qian, Huizhu Lin, Caihui Zeng, Li Yang, Jianxi Lu. Effects of different anticoagulant preservation solutions on the proliferation and killing effects of NK cells cultured in umbilical cord blood [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 572-576.
[10]	Huining Cai, Shiyu Qian, Weicai Chen, Mengchun Huang, Wenjie Chen, Jianxi Lu. Cytotoxic effect of peripheral blood NK cell proliferation in vitro on different tumor cell lines [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(04): 411-415.
[11]	Haoliang Li, Ran Zhu, Xixi Zhang, Shu Liang. The toxicity of naringenin to human corneal epithelial cells [J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2021, 11(01): 41-47.
[12]	Wenxi Cao, Xiao Chen, Laifa Zhu, Yongping Zhou. Efficacy and safety of nituzumab combined with albumin bound paclitaxel in treatment of pancreatic cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 409-413.
[13]	Gang Ren, Guangkai Shen, Yingjie Wang. Progress in research of ablation radiotherapy for pancreatic cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(12): 1276-1279.
[14]	Gang Ren, Guangkai Shen, Jiazhao Song, Jing Li, Yong Wang, Yingjie Wang. Effect of high-dose hypofractionated radiotherapy on immune function, nutritional status, and performance status in patients with pancreatic cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(09): 876-880.
[15]	Shenxin Chen, Yaqi Zhai, Baoguo Bu, Dexin Chen, Lang Wu, Kaixuan Fang, Wenjing Liu, Mingyang Li, Enqiang Linghu. Analysis of clinical features of autoimmune pancreatitis [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(01): 46-51.

Please choose a citation manager

Content to export